Correlation Between ZyVersa Therapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Candel Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Candel Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Candel Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ZyVersa and Candel is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Candel Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Candel Therapeutics. In addition to that, ZyVersa Therapeutics is 1.75 times more volatile than Candel Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Candel Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest 712.00 in Candel Therapeutics on September 4, 2024 and sell it today you would lose (261.00) from holding Candel Therapeutics or give up 36.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Candel Therapeutics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Candel Therapeutics |
ZyVersa Therapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Candel Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| ZyVersa Therapeutics vs. Candel Therapeutics | ZyVersa Therapeutics vs. Cingulate Warrants | ZyVersa Therapeutics vs. Unicycive Therapeutics | ZyVersa Therapeutics vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |